A proposed rule to limit rebates paid by drug companies to pharmacy benefit managers (PBMs) could negatively impact physicians, payers and patients.
Dea Belazi
Advertisement
Articles by Dea Belazi
Advertisement
Latest Updated Articles
Eliminating pharma rebates will raise costs for physicians and payersPublished: May 29th 2019 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
28 states reject the CDC’s new childhood vaccine schedule, KFF finds
2
Where payment fraudsters originate
3
FTC: We’ll deal with noncompetes on case-by-case basis, not via national ban
4
Payment modernization, patient experience, and revenue protection in health care
5